567 related articles for article (PubMed ID: 19733726)
21. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
22. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction.
Dabbah S; Hammerman H; Markiewicz W; Aronson D
Am J Cardiol; 2010 Feb; 105(3):312-7. PubMed ID: 20102941
[TBL] [Abstract][Full Text] [Related]
23. Additive prognostic value of NT-proBNP over TIMI risk score in intermediate-risk patients with acute coronary syndrome.
Eren NK; Ertaş F; Yüksek U; Cakir C; Nazli C; Köseoğlu M; Ergene O
Turk Kardiyol Dern Ars; 2009 Jan; 37(1):1-8. PubMed ID: 19225247
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of admission red cell distribution width as a predictor of early mortality in patients with acute pulmonary embolism.
Zorlu A; Bektasoglu G; Guven FM; Dogan OT; Gucuk E; Ege MR; Altay H; Cinar Z; Tandogan I; Yilmaz MB
Am J Cardiol; 2012 Jan; 109(1):128-34. PubMed ID: 21958741
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of N-terminal pro-B-type natriuretic peptide to predict clinical course in patients with hypertrophic cardiomyopathy.
Mutlu B; Bayrak F; Kahveci G; Degertekin M; Eroglu E; Basaran Y
Am J Cardiol; 2006 Dec; 98(11):1504-6. PubMed ID: 17126659
[TBL] [Abstract][Full Text] [Related]
26. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
Jarai R; Fellner B; Haoula D; Jordanova N; Heinz G; Karth GD; Huber K; Geppert A
Crit Care Med; 2009 Jun; 37(6):1837-44. PubMed ID: 19384228
[TBL] [Abstract][Full Text] [Related]
27. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
[TBL] [Abstract][Full Text] [Related]
28. N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients.
Guo Q; Bárány P; Qureshi AR; Snaedal S; Heimburger O; Stenvinkel P; Lindholm B; Axelsson J
Am J Nephrol; 2009; 29(6):516-23. PubMed ID: 19077418
[TBL] [Abstract][Full Text] [Related]
29. B-type natriuretic peptide is related to cardiac function and prognosis in hospitalized patients with decompensated cirrhosis.
Pimenta J; Paulo C; Gomes A; Silva S; Rocha-Gonçalves F; Bettencourt P
Liver Int; 2010 Aug; 30(7):1059-66. PubMed ID: 20492497
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis.
Ryding AD; Kumar S; Worthington AM; Burgess D
Anesthesiology; 2009 Aug; 111(2):311-9. PubMed ID: 19602961
[TBL] [Abstract][Full Text] [Related]
31. Red blood cell distribution width and its relation to cardiac function and biomarkers in a prospective hospital cohort referred for echocardiography.
Holmström A; Sigurjonsdottir R; Hammarsten O; Gustafsson D; Petzold M; Fu ML
Eur J Intern Med; 2012 Oct; 23(7):604-9. PubMed ID: 22939804
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of repeated versus single N-terminal pro B-type natriuretic peptide measurements early after-myocardial infarction.
Sandhu S; Har BJ; Aggarwal SG; Kavanagh KM; Ramadan D; Exner DV;
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S86-9. PubMed ID: 19250120
[TBL] [Abstract][Full Text] [Related]
33. Relation of smoking status to serum levels of N-terminal pro-brain natriuretic peptide in middle-aged men without overt cardiovascular disease.
Otsuka T; Kawada T; Seino Y; Ibuki C; Katsumata M; Kodani E
Am J Cardiol; 2010 Nov; 106(10):1456-60. PubMed ID: 21059436
[TBL] [Abstract][Full Text] [Related]
34. Role of N-terminal pro-brain natriuretic peptide and cystatin C to estimate renal function in patients with and without heart failure.
Linzbach S; Samigullin A; Yilmaz S; Tsioga M; Zeiher AM; Spyridopoulos I
Am J Cardiol; 2009 Apr; 103(8):1128-33. PubMed ID: 19361601
[TBL] [Abstract][Full Text] [Related]
35. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure.
Güder G; Bauersachs J; Frantz S; Weismann D; Allolio B; Ertl G; Angermann CE; Störk S
Circulation; 2007 Apr; 115(13):1754-61. PubMed ID: 17372171
[TBL] [Abstract][Full Text] [Related]
36. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension.
Torbicki A; Kurzyna M; Kuca P; Fijałkowska A; Sikora J; Florczyk M; Pruszczyk P; Burakowski J; Wawrzyńska L
Circulation; 2003 Aug; 108(7):844-8. PubMed ID: 12900346
[TBL] [Abstract][Full Text] [Related]
37. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain.
McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
Am J Cardiol; 2009 Jan; 103(1):22-8. PubMed ID: 19101224
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
[TBL] [Abstract][Full Text] [Related]
40. Pro-brain natriuretic peptide is a sensitive marker for detecting cardiac metastases in patients with non-small cell lung cancer.
Lafaras C; Mandala E; Saratzis A; Platogiannis D; Barbetakis N; Papoti S; Christopoulou M; Ilonidis G; Bischiniotis T
Onkologie; 2009 Jul; 32(7):389-92. PubMed ID: 19556815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
